FEATURED

GI Cancers Symposium 2018 Coverage

Follow our ongoing coverage of the gastrointestinal cancers symposium 2018 meeting in San Francisco, CA.

CML: Switching to Interferon?

Among female patients with CML, fertility preservation with ovarian stimulation can be challenging if patients require continuation of TKIs until HSCT.

Pancreatitis and the Risk of Cancer

Some patients diagnosed with HP or AP have a significantly increased risk of developing pancreatic cancer.

Oral Contraceptives Increase Breast Cancer Risk?

There is no evidence that women at high risk of breast cancer, such as those who harbor BRCA1 or BRCA2 mutations, should avoid hormonal contraception.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Latest Features

Could Switching to Interferon Avoid an Abnormal Ovarian Response in CML?

Could Switching to Interferon Avoid an Abnormal Ovarian Response in CML?

Among female patients with CML, fertility preservation with ovarian stimulation can be challenging if patients require continuation of TKIs until HSCT.

Pancreatitis and the Risk of Cancer

Pancreatitis and the Risk of Cancer

Some patients diagnosed with HP or AP have a significantly increased risk of developing pancreatic cancer.

Do Oral Contraceptives Actually Increase Breast Cancer Risk?

Do Oral Contraceptives Actually Increase Breast Cancer Risk?

There is no evidence that women at high risk of breast cancer, such as those who harbor BRCA1 or BRCA2 mutations, should avoid hormonal contraception.

Does Immune Checkpoint Inhibition Have A Dark Side?

Does Immune Checkpoint Inhibition Have A Dark Side?

Careful research is needed to ensure that immunotherapies activating T cells do not inadvertently fuel progression of T cell malignancies.

Encorafenib/Binimetinib Combination Shows Promise for Advanced Melanoma

Encorafenib/Binimetinib Combination Shows Promise for Advanced Melanoma

The combination may be an attractive option for some, but further research is needed to target the therapy effectively to particular patients.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs